Structure and mechanism of the mammalian fructose transporter GLUT5

Nature

Volumn 526, Issue 7573, 2015, Pages 397-401

  Nomura, Norimichi ^a,b   Verdon, Grégory ^c,d,e   Kang, Hae Joo ^c,d,e   Shimamura, Tatsuro ^a,b   Nomura, Yayoi ^a,b   Sonoda, Yo ^c   Hussien, Saba Abdul ^f   Qureshi, Aziz Abdul ^f   Coincon, Mathieu ^f   Sato, Yumi ^a,b   Abe, Hitomi ^a   Nakada Nakura, Yoshiko ^a,b   Hino, Tomoya ^a,b   Arakawa, Takatoshi ^a,b   Kusano Arai, Osamu ^g   Iwanari, Hiroko ^g   Murata, Takeshi ^a,b,h   Kobayashi, Takuya ^a,b   Hamakubo, Takao ^g   Kasahara, Michihiro ⁱ   Iwata, So ^a,b,c,d,e,h   Drew, David ^c,f   more..

^a KYOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d DIAMOND LIGHT SOURCE LTD   (United Kingdom)

^e RUTHERFORD APPLETON LABORATORY   (United Kingdom)

^f STOCKHOLM UNIVERSITY   (Sweden)

^g UNIVERSITY OF TOKYO   (Japan)

^h RIKEN   (Japan)

ⁱ TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 5; MONOSACCHARIDE; RNA; COTRANSPORTER; ESCHERICHIA COLI PROTEIN; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER 1; INORGANIC SALT; SLC2A1 PROTEIN, HUMAN; SLC2A5 PROTEIN, RAT; XYLE PROTEIN, E COLI;

BACTERIUM; CRYSTAL STRUCTURE; DIABETES; GENE EXPRESSION; GLUCOSE; MAMMAL; MUTATION; OBESITY; PROTEIN; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; ENZYME SUBSTRATE COMPLEX; ESCHERICHIA COLI; GENE SWITCHING; HUMAN; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FOLDING; RAT; RATTUS NORVEGICUS; SPLEEN CELL; SUGAR TRANSPORT; TAURINE CATTLE; ANIMAL; BINDING SITE; BOVINE; CELL MEMBRANE; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM; MOLECULAR MODEL; STATIC ELECTRICITY; STRUCTURE ACTIVITY RELATION; TRANSPORT AT THE CELLULAR LEVEL; X RAY CRYSTALLOGRAPHY;

BOS TAURUS; ESCHERICHIA COLI; MAMMALIA; RATTUS NORVEGICUS;

ANIMALS; BINDING SITES; BIOLOGICAL TRANSPORT; CATTLE; CELL MEMBRANE; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; ESCHERICHIA COLI PROTEINS; FRUCTOSE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 5; MODELS, MOLECULAR; POINT MUTATION; PROTEIN CONFORMATION; RATS; SALTS; STATIC ELECTRICITY; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; SYMPORTERS;

EID: 84944312396     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature14909     Document Type: Article

References (55)

1. Mueckler, M. & Thorens, B. The SLC2 (GLUT) family of membrane transporters. Mol. Aspects Med. 34, 121-138 (2013).
2. Zhao, F. Q. & Keating, A. F. Functional properties and genomics of glucose transporters. Curr. Genomics 8, 113-128 (2007).
3. Simpson, I. A., Vannucci, S. J. & Maher, F. Glucose transporters in mammalian brain. Biochem. Soc. Trans. 22, 671-675 (1994).
4. James, D. E., Strube, M. & Mueckler, M. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 338, 83-87 (1989).
5. Burant, C. F., Takeda, J., Brot-Laroche, E., Bell, G. I. & Davidson, N. O. Fructose transporter in human spermatozoa and small intestine is GLUT5. J. Biol. Chem. 267, 14523-14526 (1992).
6. Kayano, T. et al. Human facilitative glucose transporters. Isolation, functional characterization, and gene localization of cDNAs encoding an isoform (GLUT5) expressed in small intestine, kidney, muscle, and adipose tissue and an unusual glucose transporter pseudogene-like sequence (GLUT6). J. Biol. Chem. 265, 13276-13282 (1990).
7. Blakemore, S. J. et al. The GLUT5 hexose transporter is also localized to the basolateral membrane of the human jejunum. Biochem. J. 309, 7-12 (1995).
8. Douard, V. & Ferraris, R. P. Regulation of the fructose transporter GLUT5 in health and disease. Am. J. Physiol. Endocrinol. Metab. 295, E227-E237 (2008).
9. Rand, E.B., Depaoli, A. M.,Davidson, N. O., Bell, G. I.& Burant, C. F. Sequence, tissue distribution, and functional characterization of the rat fructose transporterGLUT5. Am. J. Physiol. 264, G1169-G1176 (1993).
10. Shepherd, P. R., Gibbs, E. M., Wesslau, C., Gould, G.W. & Kahn, B. B. Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain. Investigation of biochemical characteristics and translocation. Diabetes 41, 1360-1365 (1992).
11. Zisman, A. et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nature Med. 6, 924-928 (2000).
12. Barone, S. et al. Slc2a5 (Glut5) is essential for the absorption of fructose in the intestine and generation of fructose-induced hypertension. J. Biol. Chem. 284, 5056-5066 (2009).
13. Douard, V. & Ferraris, R. P. The role of fructose transporters in diseases linked to excessive fructose intake. J. Physiol. 591, 401-414 (2013).
14. Zamora-Leon, S. P. et al. Expression of the fructose transporter GLUT5 in human breast cancer. Proc. Natl Acad. Sci. USA 93, 1847-1852 (1996).
15. Warburg, O. On respiratory impairment in cancer cells. Science 124, 269-270 (1956).
16. Yan, N. Structural advances for the major facilitator superfamily (MFS) transporters. Trends Biochem. Sci. 38, 151-159 (2013).
17. Madej, M. G., Sun, L., Yan, N. & Kaback, H. R. Functional architecture of MFS D-glucose transporters. Proc. Natl Acad. Sci. USA 111, E719-E727 (2014).
18. Maiden, M. C., Davis, E. O., Baldwin, S. A., Moore, D. C. & Henderson, P. J. Mammalian and bacterial sugar transport proteins are homologous. Nature 325, 641-643 (1987).
19. Pao,S. S., Paulsen, I. T.&Saier, M. H. Jr. Major facilitator superfamily. Microbiol. Mol. Biol. Rev. 62, 1-34 (1998).
20. Farwick, A., Bruder, S., Schadeweg, V., Oreb, M. & Boles, E. Engineering of yeast hexose transporters to transport D-xylose without inhibition by D-glucose. Proc. Natl Acad. Sci. USA 111, 5159-5164 (2014).
21. Deng, D. et al. Crystal structure of the human glucose transporter GLUT1. Nature 510, 121-125 (2014).
22. Sun, L. et al. Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature 490, 361-366 (2012).
23. Quistgaard, E. M., Low, C., Moberg, P., Tresaugues, L. & Nordlund, P. Structural basis for substrate transport in the GLUT-homology family of monosaccharide transporters. Nature Struct. Mol. Biol. 20, 766-768 (2013).
24. Wisedchaisri, G., Park, M. S., Iadanza,M. G., Zheng, H. & Gonen, T. Proton-coupled sugar transport in the prototypical major facilitator superfamily protein XylE. Nat. Commun. 5, 4521 (2014).
25. Iancu, C. V., Zamoon, J., Woo, S. B., Aleshin, A. & Choe, J. Y. Crystal structure of a glucose/H1 symporter and itsmechanismof action. Proc.Natl Acad. Sci. USA 110, 17862-17867 (2013).
26. Garcia, J. C., Strube, M., Leingang, K., Keller, K. & Mueckler, M. M. Amino acid substitutions at tryptophan388and tryptophan412of theHepG2(Glut1) glucose transporter inhibit transport activity and targeting to the plasma membrane in Xenopus oocytes. J. Biol. Chem. 267, 7770-7776 (1992).
27. Li, Q. et al. Cloning and functional characterization of the human GLUT7 isoform SLC2A7 from the small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G236-G242 (2004).
28. Mueckler,M.&Makepeace,C.Analysis of transmembranesegment10of the Glut1 glucose transporter by cysteine-scanning mutagenesis and substituted cysteine accessibility. J. Biol. Chem. 277, 3498-3503 (2002).
29. Andersson, M. et al. Proton-coupled dynamics in lactose permease. Structure 20, 1893-1904 (2012).
30. Law, C. J. et al. Salt-bridge dynamics control substrate-induced conformational change in the membrane transporter GlpT. J. Mol. Biol. 378, 828-839 (2008).
31. Schürmann, A. et al. Role of conserved arginine and glutamate residues on the cytosolic surface of glucose transporters for transporter function. Biochemistry 36, 12897-12902 (1997).
32. Seatter, M. J., De la Rue, S. A., Porter, L. M. & Gould, G. W. QLS motif in transmembrane helix VII of the glucose transporter family interacts with the C-1 position of D-glucose and is involved in substrate selection at the exofacial binding site. Biochemistry 37, 1322-1326 (1998).
33. Hruz, P. W. & Mueckler, M. M. Cysteine-scanning mutagenesis of transmembrane segment 7 of the GLUT1 glucose transporter. J. Biol. Chem. 274, 36176-36180 (1999).
34. Manolescu,A., Salas-Burgos, A. M., Fischbarg, J.&Cheeseman,C. I. Identification of a hydrophobic residue as a key determinant of fructose transport by the facilitative hexose transporter SLC2A7 (GLUT7). J. Biol. Chem. 280, 42978-42983 (2005).
35. Kasahara, T., Maeda, M., Boles, E. & Kasahara, M. Identification of a key residue determining substrate affinity in the human glucose transporter GLUT1. Biochim. Biophys. Acta 1788, 1051-1055 (2009).
36. Karpowich, N. K. & Wang, D. N. Structural biology. Symmetric transporters for asymmetric transport. Science 321, 781-782 (2008).
37. Radestock, S. & Forrest, L. R. The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. J. Mol. Biol. 407, 698-715 (2011).
38. Solcan, N. et al. Alternating access mechanism in the POT family of oligopeptide transporters. EMBO J. 31, 3411-3421 (2012).
39. Fukuda, M. et al. Structural basis for dynamicmechanismof nitrate/nitrite antiport by NarK. Nature Commun. 6, 7097 (2015).
40. Kota, J., Gilstring, C. F. & Ljungdahl, P. O. Membrane chaperone Shr3 assists in folding amino acid permeases preventing precocious ERAD. J. Cell Biol. 176, 617-628 (2007).
41. Newstead, S., Kim, H., von Heijne, G., Iwata, S. & Drew, D. High-throughput fluorescent-based optimization of eukaryotic membrane protein overexpression and purification in Saccharomyces cerevisiae. Proc. Natl Acad. Sci. USA 104, 13936-13941 (2007).
42. Drew, D. et al. GFP-based optimization scheme for the overexpression and purification of eukaryoticmembrane proteins in Saccharomyces cerevisiae. Nature Protocols 3, 784-798 (2008).
43. Kawate, T. & Gouaux, E. Fluorescence-detection size-exclusion chromatography for precrystallization screening of integral membrane proteins. Structure 14, 673-681 (2006).
44. Sonoda, Y. et al. Benchmarking membrane protein detergent stability for improving throughput of high-resolution X-ray structures. Structure 19, 17-25 (2011).
45. Suharni, et al. Proteoliposome-based selection of a recombinant antibody fragment against the human M2 muscarinic acetylcholine receptor. Monoclon. Antib. Immunodiagn. Immunother. 33, 378-385 (2014).
46. Sonoda, Y. et al. Tricks of the trade used to accelerate high-resolution structure determination of membrane proteins. FEBS Lett. 584, 2539-2547 (2010).
47. Sarkar, H. K., Thorens, B., Lodish, H. F. & Kaback, H. R. Expression of the human erythrocyte glucose transporter in Escherichia coli. Proc. Natl Acad. Sci. USA 85, 5463-5467 (1988).
48. Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307-326 (1997).
49. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D. 50, 760-763 (1994).
50. Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D 66, 22-25 (2010).
51. Adams, P. D. et al. PHENIX: building new software for automated crystallographic structure determination. Acta Crystallogr. D 58, 1948-1954 (2002).
52. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126-2132 (2004).
53. Blanc, E. et al. Refinement of severely incomplete structures with maximum likelihood in BUSTER-TNT. Acta Crystallogr. D 60, 2210-2221 (2004).
54. Eswar, N. et al. Comparative protein structure modeling using MODELLER. Curr. Protocols Protein Sci. Ch. 2, Unit 2.9. (2007).
55. Notredame, C., Higgins, D. G. & Heringa, J. T-Coffee: A novel method for fast and accurate multiple sequence alignment. J. Mol. Biol. 302, 205-217 (2000).